Cullinan Oncology
CGEM
CGEM
106 hedge funds and large institutions have $344M invested in Cullinan Oncology in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4.77% less ownership
Funds ownership: 93.7% → 88.93% (-4.8%)
13% less capital invested
Capital invested by funds: $397M → $344M (-$53.3M)
86% less call options, than puts
Call options by funds: $80K | Put options by funds: $560K
Holders
106
Holding in Top 10
3
Calls
$80K
Puts
$560K
Top Buyers
| 1 | +$5.04M | |
| 2 | +$4.36M | |
| 3 | +$2.5M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.55M |
| 5 |
BlackRock
New York
|
+$1.2M |
Top Sellers
| 1 | -$3.07M | |
| 2 | -$2.69M | |
| 3 | -$2.48M | |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$1.24M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$901K |